Tanya Smith--founder and president of Turpentine Creek Wildlife Refuge, —recalls a precocious first foray into big cat rescue ...

In interim analysis of phase 2 ASC2ESCALATE trial, patients with chronic-phase chronic myeloid leukemia who fail to respond ...

The Board of Directors of the Central Reserve Bank (BCR) agreed to keep the reference rate steady at 4.50%. Future reference rate adjustments will be conditional on new information about inflation and ...

David Andorsky, MD, discusses efficacy and safety findings from the ASC2ESCALATE study of asciminib in chronic myeloid leukemia.

The investigational treatment DZD8586 elicited encouraging antitumor activity with manageable toxicity in heavily pretreated ...

Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to ...

Reported cumulative MMR rate of 47% (25 of 53) by 24 weeks with 32% (13 of 41) of patients achieving MMR by 24 weeks, which continues to com ...

Protara Therapeutics shows progress with TARA-002 in bladder cancer and strong financials, despite slow pipeline updates.

The camper "house" portion of the TruckHouse BCR is an aerospace-grade single-piece carbon fiber-reinforced composite shell ...

Reported cumulative MMR rate of 47% (25 of 53) by 24 weeks with 32% (13 of 41) of patients achieving MMR by 24 weeks, which continues to compare favorably to precedent ...

The updated Green Book will explicitly reject arbitrary BCR thresholds and clarify that a BCR below 1.0 (i.e. that £1 of ...